Albemarle Specialties — D&A increased by 6.3% to $28.69M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.5%, from $25.73M to $28.69M. Over 4 years (FY 2021 to FY 2025), Specialties — D&A shows an upward trend with a 12.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase often indicates significant recent capital investment in the segment, while a decrease may suggest aging assets or reduced investment.
This metric represents the non-cash expense allocated to the Specialties segment to account for the gradual wear and tea...
Standard across manufacturing peers as a component of segment-level operating expenses.
alb_segment_specialties_depreciation_and_amortization| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.66M | $16.66M | $16.66M | $16.15M | $16.91M | $16.94M | $17.70M | $19.89M | $21.30M | $22.70M | $22.78M | $22.44M | $23.17M | $24.47M | $24.96M | $25.73M | $25.67M | $27.01M | $26.98M | $28.69M |
| QoQ Change | — | +0.0% | +0.0% | -3.1% | +4.7% | +0.2% | +4.5% | +12.4% | +7.1% | +6.6% | +0.4% | -1.5% | +3.3% | +5.6% | +2.0% | +3.1% | -0.3% | +5.2% | -0.1% | +6.3% |
| YoY Change | — | — | — | — | +1.5% | +1.6% | +6.2% | +23.1% | +26.0% | +34.0% | +28.7% | +12.8% | +8.8% | +7.8% | +9.6% | +14.7% | +10.8% | +10.3% | +8.1% | +11.5% |